Location History:
- Poigny La Foret, FR (1998 - 2000)
- Sevres, FR (2004 - 2019)
Company Filing History:
10 out of 869 
4 out of 5,072 
Years Active: 1998-2019
Title: Innovator Francois Rougeon: Advancements in Antibody Research
Introduction
Francois Rougeon is a prominent inventor based in Sevres, France, known for his significant contributions to the field of antibody research. With a remarkable portfolio of 10 patents to his name, Rougeon's work focuses on innovative methods for utilizing VHH antibodies, particularly in the development of peptide vectors for delivering therapeutic substances across biological barriers.
Latest Patents
Among Rougeon's latest patents is the development surrounding the "Use of VHH antibodies for the preparation of peptide vectors for delivering a substance of interest and their applications." This invention details the employment of a variable fragment (VHH antibody) from camelids to create peptide vectors capable of crossing the blood-brain barrier or entering individual cells. Additionally, he holds a patent titled "Variable domains of camelid heavy-chain antibodies directed against glial fibrillary acidic proteins," which explores the use of VHH domains aimed at intracellular targets with specific isoelectric properties. This innovation promises potential applications in creating therapeutic and diagnostic agents targeting glial fibrillary acidic proteins.
Career Highlights
Francois Rougeon has held influential positions at notable research institutions, including the prestigious Institut Pasteur and the Centre National de la Recherche Scientifique. His work at these renowned organizations has enabled him to push the boundaries of antibody technology and its application in medicine, showcasing his commitment to advancing scientific knowledge in this critical area.
Collaborations
Throughout his career, Rougeon has collaborated with esteemed colleagues, including Catherine Rougeot and Pierre Lafaye. Their combined expertise in the field has contributed to the progress and success of various projects, ultimately leading to the innovative patents that Rougeon holds today.
Conclusion
Francois Rougeon exemplifies the spirit of innovation and dedication in the field of antibody research. His impactful patents not only highlight the potential of VHH antibodies but also pave the way for new therapeutic applications that could significantly enhance medical treatments. As he continues his work, the scientific community eagerly anticipates the future breakthroughs that may arise from his research.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.